SARAH REED: Open Payments
NPI 1598270621 · AYLETT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 27 payments from 10 companies in 2025. Trend: 2023 $47 · 2024 $406 · 2025 $565
Food & beverage: $546Education: $19
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $212 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| PFIZER INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ABBVIE INC. | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: EVENITY, REXULTI, OTEZLA, NURTEC ODT, PREVNAR 20, SHINGRIX, FREESTYLE LIBRE 3, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
